Surprise Me!
FDA Approves Drug That Costs a Whopping $700,000 a Year
2017-04-28
1
Dailymotion
The FDA has approved the first medicinal treatment for a form of Batten disease called CLN2 disease.
Please enable JavaScript to view the
comments powered by Disqus.
Related Videos
FDA approves first-ever generic version of insulin, which will dramatically cut costs
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
US: FDA approves first cancer drug based on genetics of patient
FDA approves Alzheimer's drug for further research
FDA Approves Generic ADHD Drugs
FDA Advisory Committee Unanimously Approves Eli Lilly's Alzheimer's Drug as Safe and Effective
FDA Approves First Obesity Drug in 13 Years
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
FDA approves 1st long-acting HIV drug combo, monthly shots, and other top stories in business from January 22, 2021.
FDA approves Alzheimer’s drug Aduhelm, but concerns raised about cost, effectiveness
